ChoA Pharmaceutical Co.Ltd
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral ne… Read more
ChoA Pharmaceutical Co.Ltd (034940) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.052x
Based on the latest financial reports, ChoA Pharmaceutical Co.Ltd (034940) has a cash flow conversion efficiency ratio of 0.052x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.26 Billion) by net assets (₩24.36 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ChoA Pharmaceutical Co.Ltd - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how ChoA Pharmaceutical Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ChoA Pharmaceutical Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChoA Pharmaceutical Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
My Chau Printing & Packaging Holdings Co
VN:MCP
|
N/A |
|
MAXST Co Ltd
KQ:377030
|
-0.127x |
|
Lung Ming Green Energy Technology Engineering Co Ltd
TW:3018
|
0.055x |
|
YBM Net Inc
KQ:057030
|
0.050x |
|
Thai Sugar Terminal Public Company Limited
BK:TSTE
|
0.033x |
|
Cobalt Blue Holdings Ltd
PINK:CBBHF
|
-0.121x |
|
Thitikorn Public Company Limited
BK:TK
|
0.001x |
|
Digital Workforce Services Oyj
HE:DWF
|
-0.074x |
Annual Cash Flow Conversion Efficiency for ChoA Pharmaceutical Co.Ltd (2004–2024)
The table below shows the annual cash flow conversion efficiency of ChoA Pharmaceutical Co.Ltd from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩31.38 Billion | ₩-4.47 Billion | -0.142x | -274.13% |
| 2023-12-31 | ₩38.76 Billion | ₩-1.48 Billion | -0.038x | -39.39% |
| 2022-12-31 | ₩52.84 Billion | ₩-1.44 Billion | -0.027x | +7.92% |
| 2021-12-31 | ₩49.92 Billion | ₩-1.48 Billion | -0.030x | -189.97% |
| 2020-12-31 | ₩58.30 Billion | ₩1.92 Billion | 0.033x | -57.93% |
| 2019-12-31 | ₩53.06 Billion | ₩4.16 Billion | 0.078x | +106.82% |
| 2018-12-31 | ₩53.96 Billion | ₩2.04 Billion | 0.038x | +403.82% |
| 2017-12-31 | ₩54.18 Billion | ₩-675.51 Million | -0.012x | -164.11% |
| 2016-12-31 | ₩47.84 Billion | ₩930.42 Million | 0.019x | -22.74% |
| 2015-12-31 | ₩47.15 Billion | ₩1.19 Billion | 0.025x | +85.49% |
| 2014-12-31 | ₩46.09 Billion | ₩625.52 Million | 0.014x | -80.55% |
| 2013-12-31 | ₩50.63 Billion | ₩3.53 Billion | 0.070x | -68.88% |
| 2004-12-31 | ₩15.94 Billion | ₩3.57 Billion | 0.224x | -- |